TYLENOL PM
- Product NDC
- 50580-833
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50580-833-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50580-833-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50580-833-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50580-833-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50580-833-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50580-833-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50580-833-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50580-833-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50580-833-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 50580-833-01 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Percogesic Original Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Medtech Products Inc. | 529974c2-0121-4892-8e47-c2c447581091 | 2025-01-17 | Warnings | M013 |
| Little Remedies Childrens Fever Pain Reliever | ACETAMINOPHEN | Medtech Products Inc. | e1e44c85-d10c-4997-8f85-064cda7906eb | 2025-01-17 | Warnings | M013 |
| Stanback | ASPIRIN AND CAFFEINE | Medtech Products Inc. | caaa1313-09e4-45aa-8836-346f6a370196 | 2025-01-17 | Warnings | M013 |
| Dye Free Childrens Acetaminophen | ACETAMINOPHEN | Precision Dose Inc. | 5cc698fa-0841-4851-ae21-0aac8b40eb0a | 2025-01-16 | Warnings | M013 |
| Ecotrin | ASPIRIN | Medtech Products Inc. | 222d187b-aae6-410b-baeb-b2bd42f5c676 | 2025-01-16 | Warnings | M013 |
| Children Pain and Fever Reliever | ACETAMINOPHEN | Target Corporation | 0dd643a4-3cbc-423d-95b4-ba373b09d895 | 2025-01-16 | Warnings | M013 |
| Chewable Low Dose Aspirin | ASPIRIN | TARGET CORPORATION | f934e72a-2e9f-da17-e053-6394a90a1a2e | 2025-01-15 | Warnings | M013 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 2651bf11-4d66-43ba-e054-00144ff88e88 | 2025-01-15 | Warnings | M013 |
| ASPIRIN 325 MG EC | ASPIRIN | Reliable 1 Laboratories LLC | 2ab8564f-f958-7512-e054-00144ff88e88 | 2025-01-15 | Warnings | M013 |
| ACETAMINOPHEN 325 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 25626b46-78f8-7226-e054-00144ff8d46c | 2025-01-15 | Warnings | M013 |
| Aspirin 81 mg | ASPIRIN | Reliable 1 Laboratories LLC | b247fe39-7f65-e502-e053-2a95a90a08f1 | 2025-01-15 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | e64ce7b1-4501-4b51-b012-1882ed153b42 | 2025-01-13 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN 325MG | Ulai Health LLC | 26942d32-d6e6-464d-8fc4-ffd9806d3e62 | 2025-01-12 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | WAL-MART STORES INC | a354b24e-0913-829f-e053-2995a90ad407 | 2025-01-11 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | WAL-MART STORES INC | 8f221fdb-8138-c1a8-e053-2995a90a29c2 | 2025-01-11 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | A-S Medication Solutions | 3294ba24-f198-485e-88fc-435964434b80 | 2025-01-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 32ea1230-f9ae-46b0-910e-05cd187cee34 | 2025-01-09 | Warnings | M013 |
| GeriCare Liquid Pain Relief | ACETAMINOPHEN | Geri-Care Pharmaceuticals, Corp | 85a074da-14b7-4db5-9d47-8ad19f520721 | 2025-01-06 | Warnings | M013 |
| Headache, Circle K | ACETAMINOPHEN, CAFFEINE, ASPIRIN TABLET | Lil' Drug Store Products, Inc. | e711ff0a-2fa0-1f2a-e053-2a95a90a4e38 | 2024-12-31 | Warnings | M013 |
| Extra Strength Headache, Lil Drug Store | EXTRA STRENGHT HEADACHE RELIEF- ACETAMINOPHEN, ASPIRIN, CAFFEINE TABLET | Lil' Drug Store Products, Inc. | 0c41deda-490b-f5d2-e063-6394a90a5047 | 2024-12-31 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |